OPA1 in Cardiovascular Health and Disease

被引：18
|
作者：
Burke, Niall [1 ]
Hall, Andrew R. [1 ]
Hausenloy, Derek J. [1 ,2 ,3 ]
机构：
[1] UCL, Hatter Cardiovasc Inst, 67 Chenies Mews, London WC1E 6HX, England
[2] Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore
[3] Natl Heart Ctr, Natl Heart Res Inst Singapore, Singapore, Singapore
来源：
CURRENT DRUG TARGETS | 2015年 / 16卷 / 08期
基金：
英国医学研究理事会;
关键词：
Cardiovascular disease; fission; fusion; mitochondrial morphology; OPA1; DOMINANT OPTIC ATROPHY; CYTOCHROME-C RELEASE; MITOCHONDRIAL PROTEASE OMA1; DYNAMIN-RELATED PROTEIN; PROTEOLYTIC CLEAVAGE; OXIDATIVE-PHOSPHORYLATION; RESPIRATORY-CHAIN; GTPASE OPA1; FUSION; MORPHOLOGY;
D O I：
10.2174/1389450116666150102113648
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Mitochondria are known to play crucial roles in normal cellular physiology and in more recent years they have been implicated in a wide range of pathologies. Central to both these roles is their ability to alter their shape interchangeably between two different morphologies: an elongated interconnected network and a fragmented discrete phenotype - processes which are under the regulation of the mitochondrial fusion and fission proteins, respectively. In this review article, we focus on the mitochondrial fusion protein optic atrophy protein 1 (OPA1) in cardiovascular health and disease and we explore its role as a potential therapeutic target for treating cardiovascular and metabolic disease.
引用
收藏
页码：912 / 920
页数：9
相关论文
共 50 条
  • [21] Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models
    Civiletto, Gabriele
    Varanita, Tatiana
    Cerutti, Raffaele
    Gorletta, Tatiana
    Barbaro, Serena
    Marchet, Silvia
    Lamperti, Costanza
    Viscomi, Carlo
    Scorrano, Luca
    Zeviani, Massimo
    CELL METABOLISM, 2015, 21 (06) : 845 - 854
  • [22] OPA1 and disease-causing mutants perturb mitochondrial nucleoid distribution
    Macuada, J.
    Molina-Riquelme, I.
    Vidal, G.
    Perez-Bravo, N.
    Vasquez-Trincado, C.
    Aedo, G.
    Lagos, D.
    Yu-Wai-Man, P.
    Horvath, R.
    Rudge, T. J.
    Cartes-Saavedra, B.
    Eisner, V.
    CELL DEATH & DISEASE, 2024, 15 (11):
  • [23] OPA1 dominant optic atrophy - from disease mechanisms to novel therapies
    Yu-Wai-Man, Patrick
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2024, 1865 : 20 - 20
  • [24] OPA1 gene and mitochondrial optic neuropathy: disease mechanisms and potential therapies
    Votruba, M.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [25] OPA1 and PARL keep a lid on apoptosis
    Gottlieb, Eyal
    CELL, 2006, 126 (01) : 27 - 29
  • [26] Functions and dysfunctions of the human dynamin OPA1
    Lenaers, G
    Olichon, A
    Delettre, C
    Hamel, C
    Belenguer, P
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2004, 1657 : 37 - 37
  • [27] Multi-system neurological disease is common in patients with OPA1 mutations
    Yu-Wai-Man, P.
    Griffiths, P. G.
    Gorman, G. S.
    Lourenco, C. M.
    Wright, A. F.
    Auer-Grumbach, M.
    Toscano, A.
    Musumeci, O.
    Valentino, M. L.
    Caporali, L.
    Lamperti, C.
    Tallaksen, C. M.
    Duffey, P.
    Miller, J.
    Whittaker, R. G.
    Baker, M. R.
    Jackson, M. J.
    Clarke, M. P.
    Dhillon, B.
    Czermin, B.
    Stewart, J. D.
    Hudson, G.
    Reynier, P.
    Bonneau, D.
    Marques, W., Jr.
    Lenaers, G.
    McFarland, R.
    Taylor, R. W.
    Turnbull, D. M.
    Votruba, M.
    Zeviani, M.
    Carelli, V.
    Bindoff, L. A.
    Horvath, R.
    Amati-Bonneau, P.
    Chinnery, P. F.
    BRAIN, 2010, 133 : 771 - 786
  • [28] Parkinsonism, mtDNA Multiple Deletions and Subclinical Optic Neuropathy in a 'OPA1 Plus' Family with a Novel Missense Mutation in the OPA1 Gene
    Carelli, Valerio
    La Morgia, Chiara
    Caporali, Leonardo
    Valentino, Maria Lucia
    Avoni, Patrizia
    Barboni, Piero
    Giannoccaro, Maria Pia
    Rizzo, Giovanni
    Tonon, Caterina
    Lodi, Raffaele
    Zeviani, Massimo
    Liguori, Rocco
    Montagna, Pasquale
    NEUROLOGY, 2011, 76 (09) : A412 - A413
  • [29] OPA1, the disease gene for optic atrophy type Kjer, is expressed in the inner ear
    Bette, Stefanie
    Ulrike, Zimmermann
    Bernd, Wissinger
    Knipper, Marlies
    HISTOCHEMISTRY AND CELL BIOLOGY, 2007, 128 (05) : 421 - 430
  • [30] OPA1 IN MULTIPLE MITOCHONDRIAL DNA DELETION DISORDERS
    Stewart, J. D.
    Hudson, G.
    Yu-Wai-Man, P.
    Blakeley, E. L.
    He, L.
    Horvath, R.
    Maddison, P.
    Wright, A.
    Griffiths, P. G.
    Turnbull, D. M.
    Taylor, R. W.
    Chinnery, P. F.
    NEUROLOGY, 2008, 71 (22) : 1829 - U159
12345